메뉴 건너뛰기




Volumn 97, Issue 12 SUPPL., 2006, Pages 41-52

Modifications of Coronary Risk Factors

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ATENOLOL; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; BISOPROLOL; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CARVEDILOL; CHLORTALIDONE; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FENOFIBRATE; FOSINOPRIL; FUROSEMIDE; GEMFIBROZIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LISINOPRIL; METOPROLOL; NICOTINIC ACID; NISOLDIPINE; QUINAPRIL; RAMIPRIL; TETRAHYDROLIPSTATIN; THIAZIDE DIURETIC AGENT; UNINDEXED DRUG; VERAPAMIL;

EID: 33745262387     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.03.012     Document Type: Article
Times cited : (21)

References (61)
  • 1
    • 0009547624 scopus 로고
    • American Diabetes Association Consensus Statement. Role of cardiovascular risk factors in prevention and treatment of macrovascular disease in diabetes
    • American Diabetes Association
    • American Diabetes Association. American Diabetes Association Consensus Statement. Role of cardiovascular risk factors in prevention and treatment of macrovascular disease in diabetes. Diabetes Care 12 (1989) 573-579
    • (1989) Diabetes Care , vol.12 , pp. 573-579
  • 2
    • 0032515775 scopus 로고    scopus 로고
    • Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus. United Kingdom Prospective Diabetes Study (UKPDS: 23)
    • United Kingdom Prospective Diabetes Study Group
    • Turner R.C., Millns H., Neil H.A.W., Stratton I.M., Manley S.E., Matthews D.R., Holman R.R., and United Kingdom Prospective Diabetes Study Group. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus. United Kingdom Prospective Diabetes Study (UKPDS: 23). BMJ 316 (1998) 823-828
    • (1998) BMJ , vol.316 , pp. 823-828
    • Turner, R.C.1    Millns, H.2    Neil, H.A.W.3    Stratton, I.M.4    Manley, S.E.5    Matthews, D.R.6    Holman, R.R.7
  • 3
    • 0021741512 scopus 로고
    • Interaction between cigarette smoking and diabetes mellitus in the prediction of death attributed to cardiovascular disease
    • Suarez L., and Barrett-Connor E. Interaction between cigarette smoking and diabetes mellitus in the prediction of death attributed to cardiovascular disease. Am J Epidemiol 120 (1984) 670-675
    • (1984) Am J Epidemiol , vol.120 , pp. 670-675
    • Suarez, L.1    Barrett-Connor, E.2
  • 5
    • 0037354252 scopus 로고    scopus 로고
    • Cigarette smoking and diabetes
    • Eliasson B. Cigarette smoking and diabetes. Prog Cardiovasc Dis 45 (2003) 405-413
    • (2003) Prog Cardiovasc Dis , vol.45 , pp. 405-413
    • Eliasson, B.1
  • 8
    • 84994371008 scopus 로고    scopus 로고
    • Obesity and diabetes
    • Bray G., and Bouchard C. (Eds), Marcel Dekker Inc, New York
    • Albu J., and Pi-Sunyer F.X. Obesity and diabetes. In: Bray G., and Bouchard C. (Eds). Handbook of Obesity (2004), Marcel Dekker Inc, New York 899-918
    • (2004) Handbook of Obesity , pp. 899-918
    • Albu, J.1    Pi-Sunyer, F.X.2
  • 9
    • 11844259382 scopus 로고    scopus 로고
    • Standards of medical care in diabetes 2005
    • American Diabetes Association
    • American Diabetes Association. Standards of medical care in diabetes 2005. Diabetes Care 28 suppl 1 (2005) S4-S36
    • (2005) Diabetes Care , vol.28 , Issue.SUPPL. 1
  • 10
    • 0035897696 scopus 로고    scopus 로고
    • Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
    • Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
    • Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2005) 2486-2497
    • (2005) JAMA , vol.285 , pp. 2486-2497
  • 11
    • 0035500039 scopus 로고    scopus 로고
    • AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 Update. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology
    • Smith S.C., Blair S.N., Bonow R.O., Brass L.M., Cerqueira M.D., Dracup K., Fuster V., Gotto A., Grundy S.M., Miller N.H., et al. AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 Update. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. J Am Coll Cardiol 38 (2001) 1581-1583
    • (2001) J Am Coll Cardiol , vol.38 , pp. 1581-1583
    • Smith, S.C.1    Blair, S.N.2    Bonow, R.O.3    Brass, L.M.4    Cerqueira, M.D.5    Dracup, K.6    Fuster, V.7    Gotto, A.8    Grundy, S.M.9    Miller, N.H.10
  • 12
    • 0034688194 scopus 로고    scopus 로고
    • Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
    • Heart Outcomes Prevention Evaluation Study Investigators. [published corrections appear in N Engl J Med 2000;342:748 and 2000;342:1376]
    • Yusuf S., Sleight P., Pogue J., Bosch J., Davies R., Dagenais G., and Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. [published corrections appear in N Engl J Med 2000;342:748 and 2000;342:1376]. N Engl J Med 342 (2000) 145-153
    • (2000) N Engl J Med , vol.342 , pp. 145-153
    • Yusuf, S.1    Sleight, P.2    Pogue, J.3    Bosch, J.4    Davies, R.5    Dagenais, G.6
  • 13
    • 0037840242 scopus 로고    scopus 로고
    • MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes. a randomized placebo-controlled trial
    • Heart Protection Study Collaborative Group
    • Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes. a randomized placebo-controlled trial. Lancet 361 (2003) 2005-2017
    • (2003) Lancet , vol.361 , pp. 2005-2017
  • 15
    • 0027406191 scopus 로고
    • Diabetes, other risk factors, and 12 year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial
    • Stamler J., Vaccaro O., Neaton J., and Wentworth D. Diabetes, other risk factors, and 12 year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16 (1993) 434-444
    • (1993) Diabetes Care , vol.16 , pp. 434-444
    • Stamler, J.1    Vaccaro, O.2    Neaton, J.3    Wentworth, D.4
  • 17
    • 0032554676 scopus 로고    scopus 로고
    • Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS)
    • West Scotland Coronary Prevention Group
    • West Scotland Coronary Prevention Group. Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS). Circulation 97 (1998) 1440-1445
    • (1998) Circulation , vol.97 , pp. 1440-1445
  • 19
    • 1842326783 scopus 로고    scopus 로고
    • Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease
    • Pyörälä K., Pedersen T.R., Kjekshus J., Faergeman O., Olsson A.G., and Thorgeirsson G. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. Diabetes Care 20 (1997) 614-620
    • (1997) Diabetes Care , vol.20 , pp. 614-620
    • Pyörälä, K.1    Pedersen, T.R.2    Kjekshus, J.3    Faergeman, O.4    Olsson, A.G.5    Thorgeirsson, G.6
  • 20
    • 0032497945 scopus 로고    scopus 로고
    • Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels. subgroup analyses in the Cholesterol and Recurrent Events (CARE) Trial
    • CARE Investigators
    • Goldberg R.B., Mellies M.J., Sacks F.M., Moyé L.A., Howard B.V., Howard W.J., Davis B.R., Cole T.G., Pfeffer M.A., Braunwald E., and CARE Investigators. Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels. subgroup analyses in the Cholesterol and Recurrent Events (CARE) Trial. Circulation 98 (1998) 2513-2519
    • (1998) Circulation , vol.98 , pp. 2513-2519
    • Goldberg, R.B.1    Mellies, M.J.2    Sacks, F.M.3    Moyé, L.A.4    Howard, B.V.5    Howard, W.J.6    Davis, B.R.7    Cole, T.G.8    Pfeffer, M.A.9    Braunwald, E.10
  • 21
    • 0032487931 scopus 로고    scopus 로고
    • Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
    • The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group
    • The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 339 (1998) 1349-1357
    • (1998) N Engl J Med , vol.339 , pp. 1349-1357
  • 22
    • 4344683381 scopus 로고    scopus 로고
    • Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS). multi-center randomized placebo-controlled trial
    • CARDS investigators
    • Colhoun H.M., Betteridge D.J., Durrington P.N., Hitman G.A., Neil H.A., Livingstone S.J., Thomason M.J., Mavkness M.I., Charlton-Menys V., Fuller J.H., and CARDS investigators. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS). multi-center randomized placebo-controlled trial. Lancet 364 (2005) 685-696
    • (2005) Lancet , vol.364 , pp. 685-696
    • Colhoun, H.M.1    Betteridge, D.J.2    Durrington, P.N.3    Hitman, G.A.4    Neil, H.A.5    Livingstone, S.J.6    Thomason, M.J.7    Mavkness, M.I.8    Charlton-Menys, V.9    Fuller, J.H.10
  • 23
    • 0022206133 scopus 로고
    • Lipids, diabetes, and coronary heart disease. insights from the Framingham Study
    • Kannel W.B. Lipids, diabetes, and coronary heart disease. insights from the Framingham Study. Am Heart J 110 (1985) 1100-1106
    • (1985) Am Heart J , vol.110 , pp. 1100-1106
    • Kannel, W.B.1
  • 24
    • 0037049366 scopus 로고    scopus 로고
    • Diabetes, plasma insulin and cardiovascular disease. subgroup analysis from the Department of Veterans Affairs high-density lipoprotein intervention trial (VA-HIT)
    • Rubins H.B., Robins S.J., Collins D., Nelson D.B., Elam M.B., and Schaefer E.J. Diabetes, plasma insulin and cardiovascular disease. subgroup analysis from the Department of Veterans Affairs high-density lipoprotein intervention trial (VA-HIT). Arch Intern Med 162 (2002) 2597-2604
    • (2002) Arch Intern Med , vol.162 , pp. 2597-2604
    • Rubins, H.B.1    Robins, S.J.2    Collins, D.3    Nelson, D.B.4    Elam, M.B.5    Schaefer, E.J.6
  • 26
    • 0035941990 scopus 로고    scopus 로고
    • Effect of fenofibrate on progression of coronary artery disease in type 2 diabetes. the Diabetes Atherosclerosis Intervention Study, a randomised study
    • [published correction appears in Lancet 2001;357:1890]
    • Effect of fenofibrate on progression of coronary artery disease in type 2 diabetes. the Diabetes Atherosclerosis Intervention Study, a randomised study. [published correction appears in Lancet 2001;357:1890]. Lancet 357 (2001) 905-910
    • (2001) Lancet , vol.357 , pp. 905-910
  • 27
    • 3142729178 scopus 로고    scopus 로고
    • Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines
    • Coordinating Committee of the National Cholesterol Education Program
    • Grundy S.M., Cleeman J.I., Merz C.N., Brewer Jr. H.B., Clark L.T., Hunninghake D.B., Pasternak R.C., Smith Jr. S.C., Stone N.J., and Coordinating Committee of the National Cholesterol Education Program. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 110 (2004) 227-239
    • (2004) Circulation , vol.110 , pp. 227-239
    • Grundy, S.M.1    Cleeman, J.I.2    Merz, C.N.3    Brewer Jr., H.B.4    Clark, L.T.5    Hunninghake, D.B.6    Pasternak, R.C.7    Smith Jr., S.C.8    Stone, N.J.9
  • 28
    • 0029121993 scopus 로고
    • Niacin for lipid disorders. indications, effectiveness, and safety
    • 192, 193
    • Brown W.V. Niacin for lipid disorders. indications, effectiveness, and safety. Postgrad Med 98 (1995) 185-189 192, 193
    • (1995) Postgrad Med , vol.98 , pp. 185-189
    • Brown, W.V.1
  • 29
    • 0036369914 scopus 로고    scopus 로고
    • The treatment of hypertension in adult patients with diabetes
    • Arauz-Pacheco C., Parrott M.A., and Raskin P. The treatment of hypertension in adult patients with diabetes. Diabetes Care 25 (2002) 134-147
    • (2002) Diabetes Care , vol.25 , pp. 134-147
    • Arauz-Pacheco, C.1    Parrott, M.A.2    Raskin, P.3
  • 30
    • 1042302784 scopus 로고    scopus 로고
    • Hypertension management in adults with diabetes
    • American Diabetes Association. [position statement]
    • American Diabetes Association. Hypertension management in adults with diabetes. [position statement]. Diabetes Care 27 suppl 1 (2004) S65-S67
    • (2004) Diabetes Care , vol.27 , Issue.SUPPL. 1
  • 31
    • 0038460302 scopus 로고    scopus 로고
    • The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. the JNC 7 report
    • National High Blood Pressure Education Program Coordinating Committee. [published correction appears in JAMA 2003;290:197]
    • Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo Jr. J.L., Jones D.W., Materson B.J., Oparil S., Wright Jr. J.T., Roccella E.J., and National High Blood Pressure Education Program Coordinating Committee. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. the JNC 7 report. [published correction appears in JAMA 2003;290:197]. JAMA 289 (2003) 2560-2571
    • (2003) JAMA , vol.289 , pp. 2560-2571
    • Chobanian, A.V.1    Bakris, G.L.2    Black, H.R.3    Cushman, W.C.4    Green, L.A.5    Izzo Jr., J.L.6    Jones, D.W.7    Materson, B.J.8    Oparil, S.9    Wright Jr., J.T.10    Roccella, E.J.11
  • 32
    • 0032511601 scopus 로고    scopus 로고
    • Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes. UKPDS 39
    • UK Prospective Diabetes Study Group
    • UK Prospective Diabetes Study Group. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes. UKPDS 39. BMJ 317 (1998) 713-720
    • (1998) BMJ , vol.317 , pp. 713-720
  • 33
    • 10544229794 scopus 로고    scopus 로고
    • Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension
    • Systolic Hypertension in the Elderly Program Cooperative Research Group
    • Curb J.D., Pressel S.L., Cutler J.A., Savage P.J., Applegate W.B., Black H., Camel G., Davis B.R., Frost P.H., Gonzalez N., et al., Systolic Hypertension in the Elderly Program Cooperative Research Group. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. JAMA 276 (1996) 1886-1892
    • (1996) JAMA , vol.276 , pp. 1886-1892
    • Curb, J.D.1    Pressel, S.L.2    Cutler, J.A.3    Savage, P.J.4    Applegate, W.B.5    Black, H.6    Camel, G.7    Davis, B.R.8    Frost, P.H.9    Gonzalez, N.10
  • 35
    • 0036022891 scopus 로고    scopus 로고
    • The role of angiotensin II antagonism in type 2 diabetes mellitus. a review of renoprotection studies
    • Zanella M.T., and Ribeiro A.B. The role of angiotensin II antagonism in type 2 diabetes mellitus. a review of renoprotection studies. Clin Ther 24 (2002) 1019-1034
    • (2002) Clin Ther , vol.24 , pp. 1019-1034
    • Zanella, M.T.1    Ribeiro, A.B.2
  • 36
    • 0036464234 scopus 로고    scopus 로고
    • Current recommendations for the treatment of hypertension. are they still valid?
    • Moser M. Current recommendations for the treatment of hypertension. are they still valid?. J Hypertens 20 suppl 1 (2002) S3-S10
    • (2002) J Hypertens , vol.20 , Issue.SUPPL. 1
    • Moser, M.1
  • 37
    • 0032513878 scopus 로고    scopus 로고
    • Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension. principal results of the Hypertension Optimal Treatment (HOT) randomised trial
    • HOT Study Group
    • Hansson L., Zanchetti A., Carruthers S.G., Dahlof B., Elmfeldt D., Julius S., Menard J., Rahn K.H., Wedel H., Westerling S., and HOT Study Group. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension. principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 351 (1998) 1755-1762
    • (1998) Lancet , vol.351 , pp. 1755-1762
    • Hansson, L.1    Zanchetti, A.2    Carruthers, S.G.3    Dahlof, B.4    Elmfeldt, D.5    Julius, S.6    Menard, J.7    Rahn, K.H.8    Wedel, H.9    Westerling, S.10
  • 39
    • 0344373794 scopus 로고    scopus 로고
    • Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
    • ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. [published corrections appear in JAMA 2003;289:178 and 2004;291:2196]
    • ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). [published corrections appear in JAMA 2003;289:178 and 2004;291:2196]. JAMA 288 (2002) 2981-2997
    • (2002) JAMA , vol.288 , pp. 2981-2997
  • 41
    • 7244257384 scopus 로고    scopus 로고
    • Clinical outcomes in the diabetes cohort of the International Verapamil SR-Trandolapril Study (INVEST)
    • INVEST Investigators
    • Bakris G.L., Gaxida E., Messerli F.H., Mancia G., Erdine S., Cooper-DeHoff R., Pepino C.H., and INVEST Investigators. Clinical outcomes in the diabetes cohort of the International Verapamil SR-Trandolapril Study (INVEST). Hypertension 44 (2004) 637-642
    • (2004) Hypertension , vol.44 , pp. 637-642
    • Bakris, G.L.1    Gaxida, E.2    Messerli, F.H.3    Mancia, G.4    Erdine, S.5    Cooper-DeHoff, R.6    Pepino, C.H.7
  • 42
    • 0036310610 scopus 로고    scopus 로고
    • UKPDS 60. risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine
    • UK Prospective Diabetes Study Group
    • Kothari V., Stevens R.J., Adler A.I., Stratton I.M., Manley S.E., Neil H.A., Holman R.R., and UK Prospective Diabetes Study Group. UKPDS 60. risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine. Stroke 33 (2002) 1776-1781
    • (2002) Stroke , vol.33 , pp. 1776-1781
    • Kothari, V.1    Stevens, R.J.2    Adler, A.I.3    Stratton, I.M.4    Manley, S.E.5    Neil, H.A.6    Holman, R.R.7
  • 43
    • 0036584224 scopus 로고    scopus 로고
    • UKPDS 59. hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes
    • UK Prospective Diabetes Study Group
    • Adler A.I., Stevens R.J., Neil A., Stratton I.M., Boulton A.J.M., Holman R.R., and UK Prospective Diabetes Study Group. UKPDS 59. hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes. Diabetes Care 25 (2002) 894-899
    • (2002) Diabetes Care , vol.25 , pp. 894-899
    • Adler, A.I.1    Stevens, R.J.2    Neil, A.3    Stratton, I.M.4    Boulton, A.J.M.5    Holman, R.R.6
  • 44
    • 0027966932 scopus 로고
    • Obesity, fat distribution and weight gain as risk factors for clinical diabetes in men
    • Chan J., Rimm E., Colditz G., Stampfer M., and Willett W. Obesity, fat distribution and weight gain as risk factors for clinical diabetes in men. Diabetes Care 17 (1994) 1-10
    • (1994) Diabetes Care , vol.17 , pp. 1-10
    • Chan, J.1    Rimm, E.2    Colditz, G.3    Stampfer, M.4    Willett, W.5
  • 46
    • 0036176173 scopus 로고    scopus 로고
    • Cigarette smoking predicts faster progression of type 2 established diabetic nephropathy despite ACE inhibition
    • Chuahirun T., and Wesson D.E. Cigarette smoking predicts faster progression of type 2 established diabetic nephropathy despite ACE inhibition. Am J Kidney Dis 39 (2002) 376-382
    • (2002) Am J Kidney Dis , vol.39 , pp. 376-382
    • Chuahirun, T.1    Wesson, D.E.2
  • 47
    • 0034116811 scopus 로고    scopus 로고
    • Health care and health status and outcomes for patients with type 2 diabetes
    • Harris M.I. Health care and health status and outcomes for patients with type 2 diabetes. Diabetes Care 23 (2000) 754-758
    • (2000) Diabetes Care , vol.23 , pp. 754-758
    • Harris, M.I.1
  • 48
    • 0033799018 scopus 로고    scopus 로고
    • Giving smoking cessation the attention that it deserves
    • Glasgow R.E. Giving smoking cessation the attention that it deserves. Diabetes Care 23 (2000) 1453-1454
    • (2000) Diabetes Care , vol.23 , pp. 1453-1454
    • Glasgow, R.E.1
  • 49
    • 0033803534 scopus 로고    scopus 로고
    • Intervention study for smoking cessation in diabetic patients. a randomized controlled trial in both clinical and primary care settings
    • Canga N., De Irala J., Vara E., Duaso M.J., Ferrer A., and Martinez-Gonzalez M.A. Intervention study for smoking cessation in diabetic patients. a randomized controlled trial in both clinical and primary care settings. Diabetes Care 23 (2000) 1455-1460
    • (2000) Diabetes Care , vol.23 , pp. 1455-1460
    • Canga, N.1    De Irala, J.2    Vara, E.3    Duaso, M.J.4    Ferrer, A.5    Martinez-Gonzalez, M.A.6
  • 50
    • 0034725354 scopus 로고    scopus 로고
    • A clinical practice guideline for treating tobacco use and dependence. a US Public Health Service report
    • The Tobacco Use and Dependence Clinical Practice Guideline Panel, Staff and Consortium Representatives
    • The Tobacco Use and Dependence Clinical Practice Guideline Panel, Staff and Consortium Representatives. A clinical practice guideline for treating tobacco use and dependence. a US Public Health Service report. JAMA 283 (2000) 3244-3254
    • (2000) JAMA , vol.283 , pp. 3244-3254
  • 53
    • 0030778116 scopus 로고    scopus 로고
    • The prevention and treatment of obesity. application to type 2 diabetes
    • Maggio C.A., and Pi-Sunyer F.X. The prevention and treatment of obesity. application to type 2 diabetes. Diabetes Care 20 (1997) 1744-1766
    • (1997) Diabetes Care , vol.20 , pp. 1744-1766
    • Maggio, C.A.1    Pi-Sunyer, F.X.2
  • 55
    • 0037715390 scopus 로고    scopus 로고
    • The management of the obese diabetic patient
    • Albu J., and Raja-Khan N. The management of the obese diabetic patient. Prim Care Clin Office Pract 30 (2003) 465-491
    • (2003) Prim Care Clin Office Pract , vol.30 , pp. 465-491
    • Albu, J.1    Raja-Khan, N.2
  • 56
    • 0028211087 scopus 로고
    • High mono-saturated fat diets for patients with diabetes mellitus. a meta-analysis
    • Garg A. High mono-saturated fat diets for patients with diabetes mellitus. a meta-analysis. JAMA 271 (1994) 1421-1428
    • (1994) JAMA , vol.271 , pp. 1421-1428
    • Garg, A.1
  • 57
    • 0032933426 scopus 로고    scopus 로고
    • Effects of the National Cholesterol Education Program's step I and step II dietary intervention programs of cardiovascular risk factors. a meta-analysis
    • Yu-Poh S., Zhao G., Etherton T., Naglak M., Jonnalagadda S., and Kris-Etherton P.M. Effects of the National Cholesterol Education Program's step I and step II dietary intervention programs of cardiovascular risk factors. a meta-analysis. Am J Clin Nutr 69 (1999) 632-646
    • (1999) Am J Clin Nutr , vol.69 , pp. 632-646
    • Yu-Poh, S.1    Zhao, G.2    Etherton, T.3    Naglak, M.4    Jonnalagadda, S.5    Kris-Etherton, P.M.6
  • 59
    • 1842863550 scopus 로고    scopus 로고
    • The Diabetes Prevention Program (DPP). description of lifestyle intervention
    • The Diabetes Prevention Research Group
    • The Diabetes Prevention Research Group. The Diabetes Prevention Program (DPP). description of lifestyle intervention. Diabetes Care 25 (2002) 2165-2171
    • (2002) Diabetes Care , vol.25 , pp. 2165-2171
  • 60
    • 0031261464 scopus 로고    scopus 로고
    • Management of obesity in primary care
    • Simkin-Silverman L., and Wing R.R. Management of obesity in primary care. Obes Res 5 (1997) 603-612
    • (1997) Obes Res , vol.5 , pp. 603-612
    • Simkin-Silverman, L.1    Wing, R.R.2
  • 61
    • 0032693155 scopus 로고    scopus 로고
    • ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina. a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Chronic Stable Angina)
    • [published corrections appear in J Am Coll Cardiol 1999;34:314 and 2001;38:296]
    • Gibbons R.J., Chatterjee K., Daley J., Douglas J.S., Fihn S.D., Gardin J.M., Grunwald M.A., Levy D., Lytle B.W., O'Rourke R.A., et al. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina. a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Chronic Stable Angina). [published corrections appear in J Am Coll Cardiol 1999;34:314 and 2001;38:296]. J Am Coll Cardiol 33 (1999) 2092-2197
    • (1999) J Am Coll Cardiol , vol.33 , pp. 2092-2197
    • Gibbons, R.J.1    Chatterjee, K.2    Daley, J.3    Douglas, J.S.4    Fihn, S.D.5    Gardin, J.M.6    Grunwald, M.A.7    Levy, D.8    Lytle, B.W.9    O'Rourke, R.A.10


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.